Structure and transcription of human papillomavirus sequences in cervical carcinoma cells, Nature, vol.314, issue.6006, pp.111-115, 1985. ,
The interplay between HPV and host immunity in head and neck squamous cell carcinoma, Int J Cancer, vol.134, issue.12, pp.2755-63, 2014. ,
Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer, J Infect Dis, vol.180, issue.5, pp.1415-1438, 1999. ,
Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis, Lancet Infect Dis, vol.7, issue.7, pp.453-462, 2007. ,
High incidence of cervical human papillomavirus infection in women during their first sexual relationship, BJOG, vol.109, issue.1, pp.96-104 ,
Oral HPV infection and head and neck cancers in HIV-infected individuals, Curr Opin Oncol, vol.25, issue.5, pp.503-510, 2013. ,
Human papilloma virus prevalence in HIV patients with head and neck squamous cell carcinoma, AIDS, vol.30, issue.8, pp.1257-66, 2015. ,
Données épidémiologiques sur l'infection à HPV, 2014. ,
SPLIT study group. Prevalence of human papillomavirus in tonsil brushings and gargles in cancer-free patients: The SPLIT study, Oral Oncol, vol.66, pp.201752-57 ,
Laryngeal papillomatosis with human papillomavirus DNA contracted by a laser surgeon, Eur Arch Otorhinolaryngol, vol.248, issue.7, pp.425-432, 1991. ,
Transplacental transmission of Human Papillomavirus, Virol J, vol.5, p.106, 2008. ,
Vertical transmission of human papillomavirus from infected mothers to their newborn babies and persistence of the virus in childhood, Am J Obstet Gynecol. Feb, vol.174, issue.2, pp.694-703, 1996. ,
Head and neck squamous cell carcinoma: What's new in, Ann Pathol, vol.29, issue.4, pp.265-73, 2009. ,
Human papillomavirus and oropharyngeal squamous cell carcinoma: what the clinician should know, Eur Arch Otorhinolaryngol. Feb, vol.270, issue.2, pp.405-421, 2013. ,
Periodontal disease, Porphyromonas gingivalis serum antibody levels and orodigestive cancer mortality. Carcinogenesis, pp.1055-1063, 2012. ,
Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers, J Natl Cancer Inst, vol.100, issue.6, pp.407-427, 2008. ,
Human papillomavirus genotype distribution in oropharynx and oral cavity cancer in France--The EDiTH VI study, J Clin Virol, vol.51, issue.2, pp.100-104, 2011. ,
Oropharyngeal cancer prognosis by tumour HPV status in France: The multicentric Papillophar study, Oral Oncol, vol.67, pp.201729-201765 ,
Treatment de-escalation in HPV-positive oropharyngeal carcinoma: ongoing trials, critical issues and perspectives, Int J Cancer, vol.136, issue.7, pp.1494-503, 2015. ,
HPV-associated head and neck cancer: a virus-related cancer epidemic, Lancet Oncol, vol.11, issue.8, pp.781-790, 2010. ,
Sites of predilection in recurrent respiratory papillomatosis, Ann Otol Rhinol Laryngol, vol.102, issue.8, pp.580-583, 1993. ,
Indole-3-carbinol for recurrent respiratory papillomatosis: longterm results, J Voice, pp.248-53, 2004. ,
Adjuvant drug strategies in the treatment of recurrent respiratory papillomatosis. Otolaryngol Head Neck Surg, Feb, vol.112, issue.2, pp.197-202, 1995. ,
Laryngopharyngeal reflux and laryngeal web formation in patients with pediatric recurrent respiratory papillomas, Laryngoscope, vol.112, issue.11, pp.1926-1935, 2002. ,
Acyclovir in the treatment of recurrent respiratory papillomatosis. (A pilot study), Ann Otol Rhinol Laryngol, vol.103, issue.4, pp.301-305, 1994. ,
Pilot trial of ribavirin for the treatment of laryngeal papillomatosis, Head Neck, vol.15, issue.6, pp.504-516, 1993. ,
Efficacy of DHE photodynamic therapy for respiratory papillomatosis: immediate and long-term results, Laryngoscope, vol.108, pp.962-967, 1998. ,
Systemic bevacizumab for recurrent respiratory papillomatosis: A national survey, Laryngoscope, vol.127, issue.10, pp.2225-2229, 2017. ,
Comparison of cidofovir and the measles, mumps, and rubella vaccine in the treatment of recurrent respiratory papillomatosis, Ear Nose Throat J. Feb, vol.96, issue.2, pp.69-74, 2017. ,
Clinical course of recurrent respiratory papillomatosis in Danish children, Arch Otolaryngol Head Neck Surg, vol.130, issue.6, pp.711-717, 2004. ,
Canadian Juvenile Onset Recurrent Respiratory Papillomatosis Working Group. The epidemiology of juvenile onset recurrent respiratory papillomatosis derived from a population level national database, Laryngoscope, 2010. ,
Conclusion:, The Journal of Laryngology & Otology, vol.20, issue.05, pp.425-428, 2017. ,
DOI : 10.1097/00005650-200108000-00006
Quality of life of patients with recurrent respiratory papillomatosis: QoL and Recurrent Respiratory Papillomatosis. The Laryngoscope, pp.1826-1831, 2017. ,
Risk factors for the development and severity of juvenile-onset recurrent respiratory papillomatosis: A systematic review, International Journal of Pediatric Otorhinolaryngology, pp.78-186, 2014. ,
Tracheotomy in children with recurrent respiratory papillomatosis. Head Neck, pp.226-256, 1989. ,